The Cybersecurity and Infrastructure Security Agency yesterday alerted organizations to a global phishing and spearphishing campaign targeting the COVID-19 vaccine cold chain, the part of the supply chain used to store and transport a vaccine at safe temperatures. According to an IBM X-Force report, cyber actors impersonating a biomedical company have sent emails to executives and global organizations involved in COVID-19 vaccine storage and transport to harvest credentials. The emails have posed as requests for quotations to participate in a vaccine program. CISA encourages organizations to review the report for more information.

John Riggi, AHA senior advisor for cyber and risk, said, “This alert demonstrates the need to remain vigilant and educate staff of the perils of phishing emails, the number one attack vector by cyber adversaries, because frankly it works and is fairly simple. However, the impact of clicking on a phishing email in the context of vaccine distribution could have broad public health implications.”

For more on cybersecurity and risk issues, hospital and health system leaders may contact Riggi at jriggi@aha.org.

Related News Articles

Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Cybersecurity and Infrastructure Security Agency Dec. 11 released an update to its voluntary Cybersecurity Performance Goals, which includes measurable…
Headline
U.S. and international agencies are warning of potential cyberattacks on health care and other critical infrastructure from state-sponsored cyber actors in…
Headline
A critical, unauthenticated remote code execution vulnerability known as React2Shell has been added to the Cybersecurity and Infrastructure Security Agency’s…
Headline
The FBI has public resources available to help prevent exploitation by cybercriminals, who use artificial intelligence for deception. An infographic by the FBI…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…